The impact of early ADME profiling on drug discovery and development strategy
Posted in Archive
| Tagged Academic, ADME / Tox, AI / data analytics / healthtech / informatics, Analysis, Analytical chemistry, Animal models, Assay development & optimisation, Assay development optimisation & technology, Automation / robotics, Business, Cell culture, Cellular & Molecular biology, Cellular assays, Chemistry, Clinical specialities, Clinical trials, Combinatorial chemistry, Computational chemistry, Drug development, Drug discovery, Drug targets, Enabling technologies, Genetics / genomes, Genomics, High Content Screening, High throughput screening, In Silico Biology, Lead discovery, Lead optimisation, Mass spectrometry / NMR, Molecular medicine, Organic chemistry, Patent Law, PCR, Pharmacology, Pharmokinetics, Preclinical, Protein chemistry / Proteomics, Regulatory, RNA, Screening, Stem cells, System biology, Systems biology, Therapeutics, Toxicology, Translational, Translational chemistry
